Verve Therapeutics (NASDAQ:VERV) Stock Price Expected to Rise, HC Wainwright Analyst Says
Verve Therapeutics (NASDAQ:VERV – Free Report) had its target price increased by HC Wainwright from $14.00 to $15.00 in a research note released on Friday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also recently commented on the stock. Royal Bank of Canada decreased their […]
Verve Therapeutics (NASDAQ:VERV – Free Report) had its target price increased by HC Wainwright from $14.00 to $15.00 in a research note released on Friday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other equities analysts have also recently commented on the stock. Royal Bank of Canada decreased their […]
